Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Biodiagnostic Intl — Predicate Candidate Screening

11 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

54 daysmedian FDA review time
238 days90th percentile
11clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K031296LIQUI-HEME GLYCO A1C ASSAYBiodiagnostic Intl2004-10-155410
K881430LIQUI-SERA SERUM ALCOHOL CONTROLSBiodiagnostic Intl1988-07-08940
K874459LIQUI-SERA SPINAL FLUID CONTROLBiodiagnostic Intl1987-12-29610
K863849LIQUI-SERA COMBO LIGAND/TDM CONTROLSBiodiagnostic Intl1986-11-24550
K853906LIQUI-SERA CHEMISTRY CONTROLS (COMPREHENSIVE)Biodiagnostic Intl1985-10-04140
K853887LIQUI-SERA CHEM. MULTIPLE CALIBRATORSBiodiagnostic Intl1985-09-30110
K842668LIQUI-HEME HEMOGLOBIN CALIBRATORSBiodiagnostic Intl1985-03-052380
K840618LIQUI-URA CHEMISTRY URINE CONTROLSBiodiagnostic Intl1984-04-04500
K834398LIQUI-SERA TDM CALIBRATORSBiodiagnostic Intl1984-02-03510
K834259LIQUI-URA TOXIC URINE CONTROLBiodiagnostic Intl1984-01-30540
K831278LIQUI-SERA ANTICONVULSANTS CONTROLSBiodiagnostic Intl1983-05-27380

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda